Physician profile
Scott P Stein
NPI 1659453306
$14,246.05
in general payments reported to CMS, 2019-2025
38 companies · $2,243 in 2025
The $2,243 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,777 · 2020: $1,185 · 2021: $1,690 · 2022: $2,781 · 2023: $2,426 · 2024: $2,145 · 2025: $2,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,495 · Education: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,495.40 |
| Education | $318.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,654.75 | 2019-2025 | Tavneos, Enbrel, Otezla |
| Abbvie INC. | $1,835.87 | 2019-2025 | Rinvoq, Skyrizi |
| Aurinia Pharma U.S., INC. | $1,382.10 | 2021-2024 | Lupkynis |
| Mallinckrodt Hospital Products INC. | $1,194.73 | 2020-2025 | Acthar |
| Astrazeneca Pharmaceuticals LP | $1,086.95 | 2021-2025 | Saphnelo |
| Radius Health, INC. | $757.39 | 2019-2025 | Tymlos |
| Janssen Biotech, INC. | $722.35 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $574.01 | 2019-2025 | |
| Horizon Therapeutics Plc | $571.31 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $486.67 | 2019-2025 | Orencia |
| Lilly USA, LLC | $458.51 | 2019-2025 | Taltz |
| Ucb, INC. | $375.77 | 2019-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $314.61 | 2019-2025 | |
| Intercept Pharmaceuticals, INC. | $272.93 | 2021-2025 | Ocaliva |
| Boehringer Ingelheim Pharmaceuticals, INC. | $174.50 | 2019-2025 | Cyltezo, Ofev |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.